Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Waugh

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Drugs|February 17, 1998
Recognition and management of IgA nephropathyL S Ibels, A Z Gyory, R J Caterson, et al.
Transplantation Proceedings|February 1, 1989
Abnormal serum gamma globulin concentrations in renal transplant patientsC A Pollock, J F Mahony, L S Ibels, et al.
Transplantation|June 1, 1989
Immunoglobulin abnormalities in renal transplant recipientsC A Pollock, J F Mahony, L S Ibels, et al.
Kidney International. Supplement|November 5, 1997
Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairmentL S Ibels, A Z Gyory, R J Caterson, et al.
Journal of the American Society of Nephrology : JASN|July 1, 1995
Total body nitrogen as a prognostic marker in maintenance dialysisC A Pollock, L S Ibels, B J Allen, et al.
Kidney International|March 1, 1994
Effects of erythropoietin therapy on the lipid profile in end-stage renal failureC A Pollock, R Wyndham, P V Collett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1990
Total-body nitrogen by neutron activation in maintenance dialysisC A Pollock, B J Allen, R A Warden, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Drugs|February 17, 1998
Recognition and management of IgA nephropathyL S Ibels, A Z Gyory, R J Caterson, et al.
Transplantation Proceedings|February 1, 1989
Abnormal serum gamma globulin concentrations in renal transplant patientsC A Pollock, J F Mahony, L S Ibels, et al.
Transplantation|June 1, 1989
Immunoglobulin abnormalities in renal transplant recipientsC A Pollock, J F Mahony, L S Ibels, et al.
Kidney International. Supplement|November 5, 1997
Primary IgA nephropathy: natural history and factors of importance in the progression of renal impairmentL S Ibels, A Z Gyory, R J Caterson, et al.
Journal of the American Society of Nephrology : JASN|July 1, 1995
Total body nitrogen as a prognostic marker in maintenance dialysisC A Pollock, L S Ibels, B J Allen, et al.
Kidney International|March 1, 1994
Effects of erythropoietin therapy on the lipid profile in end-stage renal failureC A Pollock, R Wyndham, P V Collett, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 1, 1990
Total-body nitrogen by neutron activation in maintenance dialysisC A Pollock, B J Allen, R A Warden, et al.
Pageof 2